The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Healthcare-associated Infectious Disease Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Healthcare-associated Infectious Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Healthcare-associated Infectious Disease Diagnostics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Healthcare-associated Infectious Disease Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Urinary Tract Infections segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Healthcare-associated Infectious Disease Diagnostics include Abbott, Accelerate Diagnostics, BD, bioMrieux, and Bio-Rad, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Healthcare-associated Infectious Disease Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Urinary Tract Infections
Surgical Site Infections
Hospital-acquired Pneumonia
BloodStream Infections
Gastrointestinal Infections
Market segment by Application, can be divided into
Hospitals
Clinics
ASCs
Market segment by players, this report covers
Abbott
Accelerate Diagnostics
BD
bioMrieux
Bio-Rad
DiaSorin Molecular
F. Hoffmann-La Roche
Luminex
Meridian Bioscience
OpGen
QIAGEN
Quidel
Thermo Fisher Scientific
Trinity Biotech
Danaher
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Healthcare-associated Infectious Disease Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Healthcare-associated Infectious Disease Diagnostics, with revenue, gross margin and global market share of Healthcare-associated Infectious Disease Diagnostics from 2019 to 2022.
Chapter 3, the Healthcare-associated Infectious Disease Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Healthcare-associated Infectious Disease Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Healthcare-associated Infectious Disease Diagnostics research findings and conclusion, appendix and data source.
Geographical Area
Global
The Healthcare-associated Infectious Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Healthcare-associated Infectious Disease Diagnostics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Healthcare-associated Infectious Disease Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Urinary Tract Infections segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Healthcare-associated Infectious Disease Diagnostics include Abbott, Accelerate Diagnostics, BD, bioMrieux, and Bio-Rad, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Healthcare-associated Infectious Disease Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Urinary Tract Infections
Surgical Site Infections
Hospital-acquired Pneumonia
BloodStream Infections
Gastrointestinal Infections
Market segment by Application, can be divided into
Hospitals
Clinics
ASCs
Market segment by players, this report covers
Abbott
Accelerate Diagnostics
BD
bioMrieux
Bio-Rad
DiaSorin Molecular
F. Hoffmann-La Roche
Luminex
Meridian Bioscience
OpGen
QIAGEN
Quidel
Thermo Fisher Scientific
Trinity Biotech
Danaher
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Healthcare-associated Infectious Disease Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Healthcare-associated Infectious Disease Diagnostics, with revenue, gross margin and global market share of Healthcare-associated Infectious Disease Diagnostics from 2019 to 2022.
Chapter 3, the Healthcare-associated Infectious Disease Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Healthcare-associated Infectious Disease Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Healthcare-associated Infectious Disease Diagnostics research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Healthcare-associated Infectious Disease Diagnostics
1.2 Classification of Healthcare-associated Infectious Disease Diagnostics by Type
1.2.1 Overview: Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type in 2021
1.2.3 Urinary Tract Infections
1.2.4 Surgical Site Infections
1.2.5 Hospital-acquired Pneumonia
1.2.6 BloodStream Infections
1.2.7 Gastrointestinal Infections
1.3 Global Healthcare-associated Infectious Disease Diagnostics Market by Application
1.3.1 Overview: Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Global Healthcare-associated Infectious Disease Diagnostics Market Size & Forecast
1.5 Global Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast by Region
1.5.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Healthcare-associated Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Healthcare-associated Infectious Disease Diagnostics Market Drivers
1.6.2 Healthcare-associated Infectious Disease Diagnostics Market Restraints
1.6.3 Healthcare-associated Infectious Disease Diagnostics Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.1.4 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Accelerate Diagnostics
2.2.1 Accelerate Diagnostics Details
2.2.2 Accelerate Diagnostics Major Business
2.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.2.4 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Accelerate Diagnostics Recent Developments and Future Plans
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.3.4 BD Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BD Recent Developments and Future Plans
2.4 bioMrieux
2.4.1 bioMrieux Details
2.4.2 bioMrieux Major Business
2.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.4.4 bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 bioMrieux Recent Developments and Future Plans
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business
2.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.5.4 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Bio-Rad Recent Developments and Future Plans
2.6 DiaSorin Molecular
2.6.1 DiaSorin Molecular Details
2.6.2 DiaSorin Molecular Major Business
2.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.6.4 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 DiaSorin Molecular Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche
2.7.1 F. Hoffmann-La Roche Details
2.7.2 F. Hoffmann-La Roche Major Business
2.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.7.4 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.8 Luminex
2.8.1 Luminex Details
2.8.2 Luminex Major Business
2.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.8.4 Luminex Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Luminex Recent Developments and Future Plans
2.9 Meridian Bioscience
2.9.1 Meridian Bioscience Details
2.9.2 Meridian Bioscience Major Business
2.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.9.4 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Meridian Bioscience Recent Developments and Future Plans
2.10 OpGen
2.10.1 OpGen Details
2.10.2 OpGen Major Business
2.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.10.4 OpGen Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 OpGen Recent Developments and Future Plans
2.11 QIAGEN
2.11.1 QIAGEN Details
2.11.2 QIAGEN Major Business
2.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.11.4 QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 QIAGEN Recent Developments and Future Plans
2.12 Quidel
2.12.1 Quidel Details
2.12.2 Quidel Major Business
2.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.12.4 Quidel Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Quidel Recent Developments and Future Plans
2.13 Thermo Fisher Scientific
2.13.1 Thermo Fisher Scientific Details
2.13.2 Thermo Fisher Scientific Major Business
2.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.13.4 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.14 Trinity Biotech
2.14.1 Trinity Biotech Details
2.14.2 Trinity Biotech Major Business
2.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.14.4 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Trinity Biotech Recent Developments and Future Plans
2.15 Danaher
2.15.1 Danaher Details
2.15.2 Danaher Major Business
2.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Product and Solutions
2.15.4 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Danaher Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Healthcare-associated Infectious Disease Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Healthcare-associated Infectious Disease Diagnostics Players Market Share in 2021
3.2.2 Top 10 Healthcare-associated Infectious Disease Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Healthcare-associated Infectious Disease Diagnostics Players Head Office, Products and Services Provided
3.4 Healthcare-associated Infectious Disease Diagnostics Mergers & Acquisitions
3.5 Healthcare-associated Infectious Disease Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Healthcare-associated Infectious Disease Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2028)
6.2 North America Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2028)
6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2028)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2028)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Region (2017-2028)
8.3.2 China Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2028)
9.2 South America Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2028)
9.3 South America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
9.3.1 South America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Healthcare-associated Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Healthcare-associated Infectious Disease Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 9. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Accelerate Diagnostics Corporate Information, Head Office, and Major Competitors
Table 11. Accelerate Diagnostics Major Business
Table 12. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 13. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BD Corporate Information, Head Office, and Major Competitors
Table 15. BD Major Business
Table 16. BD Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 17. BD Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. bioMrieux Corporate Information, Head Office, and Major Competitors
Table 19. bioMrieux Major Business
Table 20. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 21. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 23. Bio-Rad Major Business
Table 24. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 25. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. DiaSorin Molecular Corporate Information, Head Office, and Major Competitors
Table 27. DiaSorin Molecular Major Business
Table 28. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 29. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 31. F. Hoffmann-La Roche Major Business
Table 32. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 33. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Luminex Corporate Information, Head Office, and Major Competitors
Table 35. Luminex Major Business
Table 36. Luminex Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 37. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Meridian Bioscience Corporate Information, Head Office, and Major Competitors
Table 39. Meridian Bioscience Major Business
Table 40. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 41. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. OpGen Corporate Information, Head Office, and Major Competitors
Table 43. OpGen Major Business
Table 44. OpGen Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 45. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 47. QIAGEN Major Business
Table 48. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 49. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Quidel Corporate Information, Head Office, and Major Competitors
Table 51. Quidel Major Business
Table 52. Quidel Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 53. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 55. Thermo Fisher Scientific Major Business
Table 56. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 57. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Trinity Biotech Corporate Information, Head Office, and Major Competitors
Table 59. Trinity Biotech Major Business
Table 60. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 61. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Danaher Corporate Information, Head Office, and Major Competitors
Table 63. Danaher Major Business
Table 64. Danaher Healthcare-associated Infectious Disease Diagnostics Product and Solutions
Table 65. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Healthcare-associated Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Healthcare-associated Infectious Disease Diagnostics Players Head Office, Products and Services Provided
Table 70. Healthcare-associated Infectious Disease Diagnostics Mergers & Acquisitions in the Past Five Years
Table 71. Healthcare-associated Infectious Disease Diagnostics New Entrants and Expansion Plans
Table 72. Global Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 73. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Type (2017-2022)
Table 74. Global Healthcare-associated Infectious Disease Diagnostics Revenue Forecast by Type (2023-2028)
Table 75. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2022)
Table 76. Global Healthcare-associated Infectious Disease Diagnostics Revenue Forecast by Application (2023-2028)
Table 77. North America Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Healthcare-associated Infectious Disease Diagnostics Picture
Figure 2. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type in 2021
Figure 3. Urinary Tract Infections
Figure 4. Surgical Site Infections
Figure 5. Hospital-acquired Pneumonia
Figure 6. BloodStream Infections
Figure 7. Gastrointestinal Infections
Figure 8. Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application in 2021
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. ASCs Picture
Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028)
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Region in 2021
Figure 16. North America Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Figure 22. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Figure 23. Healthcare-associated Infectious Disease Diagnostics Market Trends
Figure 24. Abbott Recent Developments and Future Plans
Figure 25. Accelerate Diagnostics Recent Developments and Future Plans
Figure 26. BD Recent Developments and Future Plans
Figure 27. bioMrieux Recent Developments and Future Plans
Figure 28. Bio-Rad Recent Developments and Future Plans
Figure 29. DiaSorin Molecular Recent Developments and Future Plans
Figure 30. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 31. Luminex Recent Developments and Future Plans
Figure 32. Meridian Bioscience Recent Developments and Future Plans
Figure 33. OpGen Recent Developments and Future Plans
Figure 34. QIAGEN Recent Developments and Future Plans
Figure 35. Quidel Recent Developments and Future Plans
Figure 36. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 37. Trinity Biotech Recent Developments and Future Plans
Figure 38. Danaher Recent Developments and Future Plans
Figure 39. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Players in 2021
Figure 40. Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Healthcare-associated Infectious Disease Diagnostics Revenue Market Share in 2021
Figure 42. Global Top 10 Players Healthcare-associated Infectious Disease Diagnostics Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Type in 2021
Figure 45. Global Healthcare-associated Infectious Disease Diagnostics Market Share Forecast by Type (2023-2028)
Figure 46. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Application in 2021
Figure 47. Global Healthcare-associated Infectious Disease Diagnostics Market Share Forecast by Application (2023-2028)
Figure 48. North America Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 49. North America Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 50. North America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 51. United States Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 55. Europe Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 56. Europe Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 57. Germany Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028)
Figure 65. China Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 72. South America Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 73. South America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Healthcare-associated Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
